Owner VasGene Therapeutics, Inc.

Inventors Reddy, Ramachandra; Gill, Parkash

Agent Shelston IP

Pub. Number AU-B-2004220525

PCT Pub. Number WO2004/080418

Priority 60/454,432 12.03.03 US; 60/454,300 12.03.03 US

Filing date 12 March 2004

Wipo publication date 23 September 2004

Acceptance publication date 31 March 2011

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 35/00 (2006.01) Antineoplastic agents

C07K 5/00 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 14/715 (2006.01) Peptides having more than 20 amino acids

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides